Medicine for treating lipopolysaccharide/D-aminogalactose induced liver injury
A technology for galactosamine and liver damage, which is applied in the field of clinical medicine and can solve problems such as unclear effects of liver damage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0020] In order to make the object, technical solution and advantages of the present invention more clear, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
[0021] The application principle of the present invention will be described in detail below in conjunction with the accompanying drawings.
[0022] like figure 1 As shown, the method for constructing a model of a drug for verifying the treatment of lipopolysaccharide / D-galactosamine-induced liver injury provided by the embodiments of the present invention includes the following steps:
[0023] S101: Seventy-five mice were randomly divided into five groups, each group containing 15 mice;
[0024] S102: Group I, normal control group, mice received the same amount of PBS; Group II, model control group, mice received GalN800 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com